Novocure (NVCR) Misses Q1 EPS by 18c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.50), $0.18 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $122.2 million versus the consensus estimate of $127.37 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Deere & Co. (DE) Tops Q2 EPS by 66c; Cuts net income forecast
• Aileron Therapeutics (ALRN) Tops Q1 EPS by 16c
• Pro Diversity Network (IPDN) Misses Q1 EPS by 7c